1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Rates of glycaemic deterioration in a real-world population with type 2 diabetes (
- Formalising recall by genotype as an efficient approach to detailed phenotyping and causal inference (
- 2017
- Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes (
- Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes (
- Predicting glycated hemoglobin levels in the non-diabetic general population : Development and validation of the DIRECTDETECT prediction model-a DIRECT study (
- 2016
- Statistical power considerations in genotype-based recall randomized controlled trials (
- 2014
- Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study (
- Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis. (
- 2013
- The CTRB1/2 Locus Affects Diabetes Susceptibility and Treatment via the Incretin Pathway (